348 related articles for article (PubMed ID: 12960047)
1. Autocrine/paracrine action of pituitary vasoactive intestinal peptide on lactotroph hyperplasia induced by estrogen.
Gómez O; Balsa JA
Endocrinology; 2003 Oct; 144(10):4403-9. PubMed ID: 12960047
[TBL] [Abstract][Full Text] [Related]
2. Implication of pituitary vasoactive intestinal peptide in dopaminergic inhibition of estrogen-induced pituitary hyperplasia and vascular endothelial growth factor expression.
Gómez O; Balsa JA
Neuroendocrinology; 2004; 80(5):324-31. PubMed ID: 15677882
[TBL] [Abstract][Full Text] [Related]
3. Prolactin gene expression and secretion during pregnancy and lactation in the rat: role of dopamine and vasoactive intestinal peptide.
Escalada J; Cacicedo L; Ortego J; Melian E; Sánchez-Franco F
Endocrinology; 1996 Feb; 137(2):631-7. PubMed ID: 8593812
[TBL] [Abstract][Full Text] [Related]
4. Autocrine and/or paracrine action of vasoactive intestinal peptide on thyrotropin-releasing hormone induced prolactin release.
Balsa JA; Cacicedo L; Lara JI; Lorenzo MJ; Pazos F; Sanchez-Franco F
Endocrinology; 1996 Jan; 137(1):144-50. PubMed ID: 8536606
[TBL] [Abstract][Full Text] [Related]
5. Quantification of vasoactive intestinal peptide immunoreactivity in the anterior pituitary glands of intact male and female, ovariectomized, and estradiol benzoate-treated rats.
Carrillo AJ; Phelps CJ
Endocrinology; 1992 Aug; 131(2):964-9. PubMed ID: 1639033
[TBL] [Abstract][Full Text] [Related]
6. Preferential increase in pituitary prolactin versus vasoactive intestinal peptide as a function of estradiol benzoate dose in the ovariectomized rat.
Carrillo AJ; Doherty PC; Guan XB; Sturtevant JR; Walro DG
Endocrinology; 1991 Jan; 128(1):131-8. PubMed ID: 1986914
[TBL] [Abstract][Full Text] [Related]
7. Estrogen increases galanin immunoreactivity in hyperplastic prolactin-secreting cells in Fisher 344 rats.
Hsu DW; el-Azouzi M; Black PM; Chin WW; Hedley-Whyte ET; Kaplan LM
Endocrinology; 1990 Jun; 126(6):3159-67. PubMed ID: 1693569
[TBL] [Abstract][Full Text] [Related]
8. Estrogen regulates the gene expression of vasoactive intestinal peptide in the anterior pituitary.
Lam KS; Srivastava G; Lechan RM; Lee T; Reichlin S
Neuroendocrinology; 1990 Nov; 52(5):417-21. PubMed ID: 2126350
[TBL] [Abstract][Full Text] [Related]
9. Divergent effects of glucocorticoid on the gene expression of vasoactive intestinal peptide in the rat cerebral cortex and pituitary.
Lam KS; Srivastava G; Tam SP
Neuroendocrinology; 1992 Jul; 56(1):32-7. PubMed ID: 1641071
[TBL] [Abstract][Full Text] [Related]
10. Presence of immunoreactive vasoactive intestinal polypeptide in anterior pituitary of normal male and long term estrogen-treated female rats: a light microscopic immunohistochemical study.
Köves K; Gottschall PE; Görcs T; Scammell JG; Arimura A
Endocrinology; 1990 Mar; 126(3):1756-63. PubMed ID: 1689657
[TBL] [Abstract][Full Text] [Related]
11. Inhibitory effect of thalidomide on the growth, secretory function and angiogenesis of estrogen-induced prolactinoma in Fischer 344 rats.
Stepień H; Lawnicka H; Mucha S; Wagrowska-Danilewicz M; Stepień B; Siejka A; Komorowski J
Life Sci; 2006 Sep; 79(18):1741-8. PubMed ID: 16846617
[TBL] [Abstract][Full Text] [Related]
12. Autoparacrine action of vasoactive intestinal peptide on dopaminergic control of prolactin secretion.
Balsa JA; Sánchez-Franco F; Lorenzo MJ; Pazos F; Lara JI; Cacicedo L
Endocrinology; 1996 Feb; 137(2):508-13. PubMed ID: 8593796
[TBL] [Abstract][Full Text] [Related]
13. Role of transforming growth factor (TGF)-beta Type I and TGF-beta type II receptors in the TGF-beta1-regulated gene expression in pituitary prolactin-secreting lactotropes.
Sarkar DK; Pastorcic M; De A; Engel M; Moses H; Ghasemzadeh MB
Endocrinology; 1998 Aug; 139(8):3620-8. PubMed ID: 9681516
[TBL] [Abstract][Full Text] [Related]
14. Vasoactive intestinal polypeptide antiserum affects rat prolactin mRNA in 40-day but not 110-day diethylstilbestrol-induced prolactinoma tissue.
Maas DL; Meier DA; Wahle JS; Martinson DR; Hagen TC
Mol Cell Neurosci; 1994 Apr; 5(2):182-8. PubMed ID: 8032686
[TBL] [Abstract][Full Text] [Related]
15. Induction of vasoactive intestinal peptide gene expression and prolactin secretion by insulin-like growth factor I in rat pituitary cells: evidence for an autoparacrine regulatory system.
Lara JI; Lorenzo MJ; Cacicedo L; Tolón RM; Balsa JA; López-Fernández J; Sánchez-Franco F
Endocrinology; 1994 Dec; 135(6):2526-32. PubMed ID: 7988440
[TBL] [Abstract][Full Text] [Related]
16. Chronic estrogen treatment promotes a functional uncoupling of the D2 dopamine receptor in rat anterior pituitary gland.
Munemura M; Agui T; Sibley DR
Endocrinology; 1989 Jan; 124(1):346-55. PubMed ID: 2521206
[TBL] [Abstract][Full Text] [Related]
17. Estrogen-induced hyperplasia and neoplasia in the rat anterior pituitary gland. An immunohistochemical study.
Lloyd RV
Am J Pathol; 1983 Nov; 113(2):198-206. PubMed ID: 6638150
[TBL] [Abstract][Full Text] [Related]
18. Antiproliferative action of calcitonin on lactotrophs of the rat anterior pituitary gland: evidence for the involvement of transforming growth factor beta 1 in calcitonin action.
Wang YQ; Yuan R; Sun YP; Lee TJ; Shah GV
Endocrinology; 2003 May; 144(5):2164-71. PubMed ID: 12697724
[TBL] [Abstract][Full Text] [Related]
19. Effect of concomitant progesterone administration or the effect of removal of estrogen capsule on changes caused by long-term estrogen treatment in pituitary VIP immunoreactivities.
Heinzlmann A; Köves K; Nagy GM
Endocrine; 2010 Jun; 37(3):396-402. PubMed ID: 20960159
[TBL] [Abstract][Full Text] [Related]
20. Vasoactive intestinal peptide and the stimulation of lactotroph growth by oestradiol in rats.
Prysor-Jones RA; Silverlight JJ; Kennedy SJ; Jenkins JS
J Endocrinol; 1988 Feb; 116(2):259-65. PubMed ID: 3351421
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]